Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$27,409,257
-$1,350,548 QoQ
Shares Held
475,690
+0.3% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
#236
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HANCOCK WHITNEY CORP holds $246,232,753 across 10 Drug Manufacturers - General names. BMY ranks #6 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
218,107 | $55,392,634 | |
| 2 | AMGN |
Amgen Inc
|
143,155 | $51,839,288 | |
| 3 | MRK |
Merck & Co., Inc.
|
291,028 | $37,397,097 | |
| 4 | LLY |
ELI LILLY & Co
|
27,853 | $33,407,725 | |
| 5 | ABBV |
AbbVie Inc.
|
121,958 | $30,689,510 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
475,690 | $27,409,257 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
36,474 | $4,608,124 | |
| 8 | PFE |
Pfizer Inc
|
140,375 | $3,380,229 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,409,257 | 475,690 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $28,759,805 | 474,193 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $26,107,066 | 484,002 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $21,534,933 | 477,493 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $15,341,106 | 331,413 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $19,580,472 | 321,044 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $18,218,823 | 322,115 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $16,505,472 | 319,008 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,008,804 | 24,291 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $1,331,617 | 24,555 | Shares | Other | 2024-05-16 | |
| 2023-12-31 | $1,189,878 | 23,190 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,577,526 | 27,180 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,781,710 | 27,861 | Shares | Sole | 2023-11-13 | |
| 2023-03-31 | $1,848,982 | 26,677 | Shares | Sole | 2023-11-13 | |
| 2022-12-31 | $1,822,636 | 25,332 | Shares | Sole | 2023-11-13 | |
| 2022-09-30 | $1,934,998 | 27,219 | Shares | Sole | 2022-10-26 | |
| 2022-06-30 | $2,098,481 | 27,253 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $1,965,894 | 26,919 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,668,236 | 26,756 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $1,594,926 | 26,955 | Shares | Other | 2021-11-04 | |
| 2021-06-30 | $1,884,724 | 28,206 | Shares | Other | 2021-08-09 | |
| 2021-03-31 | $1,887,459 | 29,898 | Shares | Other | 2021-05-14 | |
| 2020-12-31 | $2,096,613 | 33,800 | Shares | Other | 2021-02-09 | |
| 2020-09-30 | $2,083,923 | 34,565 | Shares | Other | 2020-11-05 | |
| 2020-06-30 | $2,087,517 | 35,502 | Shares | Other | 2020-07-30 | |
| 2020-03-31 | $1,494,221 | 26,807 | Shares | Other | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||